Janet Dillione sold $467k of CRMD
director at CorMedix Inc.. 46,657 shares at an average of $10.00, traded Dec 2, 2025, filed Dec 4, 2025.
Score components
- +15RoleDirector
- +17Trade size$467k at market
- +10Share of holdings soldSold 49% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +14.3%, 3m -40.8%, 6m -19.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-118433, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2025 | MOption exercise Common Stock10b5-1 | +12,210 | $4.03 | $49k | 60,683 | Dec 4, 2025 |
| Dec 2, 2025 | MOption exercise Common Stock10b5-1 | +15,124 | $4.43 | $67k | 75,807 | Dec 4, 2025 |
| Dec 2, 2025 | MOption exercise Common Stock10b5-1 | +19,323 | $3.55 | $69k | 95,130 | Dec 4, 2025 |
| Dec 2, 2025 | SOpen-market sale Common Stock10b5-1 | -46,657 | $10.00 | $467k | 48,473 | Dec 4, 2025 |
| Dec 2, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -12,210 | $0.00 | $0 | 0 | Dec 4, 2025 |
| Dec 2, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -15,124 | $0.00 | $0 | 0 | Dec 4, 2025 |
| Dec 2, 2025 | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -19,323 | $0.00 | $0 | 5,000 | Dec 4, 2025 |
Related signals
Other insiders at CorMedix Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | CorMedix Inc. | Janet Dillione director | $69k 10,000 shares | -21% | |
| 11Weak | CorMedix Inc. | Alan W Dunton director | $260k 20,000 shares | -33% | |
| 20Weak | CorMedix Inc. | Joseph Todisco Chief Executive Officer | $360k 30,000 shares | -6% | |
| 21Weak | CorMedix Inc. | Janet Dillione director | $408k 34,000 shares | -41% | |
| 58Moderate | CorMedix Inc. | Steven W Lefkowitz director | $475k 40,000 shares | -33% | |
| 23Weak | CRMDsell CorMedix Inc. | Janet Dillione director | $262k 26,343 shares | -35% | |
| 40Moderate | CRMDsell CorMedix Inc. | Janet Dillione director | $343k 30,000 shares | -38% | |
| 40Moderate | CRMDbuy CorMedix Inc. | Myron Kaplan director | $276k 25,000 shares | +14% | |
| 31Weak | CorMedix Inc. | Alan W Dunton director | $131k 10,000 shares | -20% | |
| 45Moderate | CorMedix Inc. | Joseph Todisco Chief Executive Officer | $650k 50,000 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.